VCIM
NMTR

Velan Capital Investment Management’s 9 Meters Biopharma NMTR Stock Holding History

Velan Capital Investment Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-216,415
Closed -$4.24M – 31
2021
Q4 		$4.24M Buy
+216,415
New +$4.84M 3.29% 8

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Velan Capital Investment Management's NMTR Position: Q1 2022 in Review

Velan Capital Investment Management sold out of 9 Meters Biopharma (NMTR) in Q1 2022, closing a stake of 216,415 shares — an estimated $4.24M sold.

Velan Capital Investment Management first reported a position in NMTR in Q4 2021 and held it in 1 quarter. The position peaked at $4.24M in Q4 2021. 101 funds tracked by Wall St. Rank hold NMTR as of Q1 2022.

  • Velan Capital Investment Management reported no remaining 9 Meters Biopharma position as of Q1 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 216,415 9 Meters Biopharma shares in Q1 2022, an estimated $4.24M.
  • Velan Capital Investment Management first reported a position in 9 Meters Biopharma in Q4 2021 and held it in 1 quarter.
  • Velan Capital Investment Management's 9 Meters Biopharma position peaked at $4.24M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2022.

Based on Velan Capital Investment Management's 13F filing for Q1 2022, filed 16 May 2022.